Health Technology Kobayashi Pharmaceutical Co., Ltd. Business Summary
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Financial Highlights
Dec 2021
JPY USD Revenue 155,252M 1,413.01M Gross Profit 86,379M 786.16M Operating income 25,846M 235.23M Income before tax 27,636M 251.52M Net income 19,715M 179.43M EBITDA 30,681M 279.24M Diluted EPS 252.35 2.29 Dividends Per Share 83 0.75 Total Assets 252,554M 2,193.16M Total liabilities 56,952M 494.56M Total equity 195,600M 1,698.58M Operating cash flow 22,419M 204.04M Currency in JPY Currency in USD
Historical Data Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Revenue
156,761M
167,479M
158,340M
150,514M
155,252M
Gross Profit
94,189M
101,963M
89,689M
84,125M
86,379M
Operating income
22,809M
26,191M
25,512M
25,809M
25,846M
Income before tax
22,572M
25,304M
26,804M
26,635M
27,636M
Net income
15,863M
18,023M
19,139M
19,205M
19,715M
EBITDA
26,328M
29,594M
29,639M
29,915M
30,681M
Diluted EPS
201.02
227.95
244.07
245.70
252.35
Dividends Per Share
58
66
73
77
83
Total Assets
218,831M
228,787M
233,732M
238,366M
252,554M
Total liabilities
65,016M
62,536M
61,072M
55,781M
56,952M
Total equity
153,811M
166,249M
172,657M
182,583M
195,600M
Operating cash flow
22,350M
20,007M
20,089M
23,986M
22,419M
Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Revenue
1,397.98M
1,516.43M
1,452.51M
1,409.72M
1,413.01M
Gross Profit
839.97M
923.21M
822.75M
787.91M
786.16M
Operating income
203.40M
237.14M
234.03M
241.72M
235.23M
Income before tax
201.29M
229.11M
245.88M
249.46M
251.52M
Net income
141.46M
163.18M
175.56M
179.87M
179.43M
EBITDA
234.79M
267.95M
271.89M
280.18M
279.24M
Diluted EPS
1.79
2.06
2.23
2.30
2.29
Dividends Per Share
0.51
0.59
0.66
0.72
0.75
Total Assets
1,942.57M
2,085.28M
2,150.74M
2,308.74M
2,193.16M
Total liabilities
577.15M
569.98M
561.96M
540.27M
494.56M
Total equity
1,365.38M
1,515.28M
1,588.74M
1,768.44M
1,698.58M
Operating cash flow
199.31M
181.15M
184.28M
224.65M
204.04M
Valuation Measures
Dec 2021
PER 35.82 ROA 8.03% ROE 10.42% Operating margin 16.64% Profit margin 12.69%
Key executives
President & Representative Director:
Akihiro Kobayashi
Manager-Finance & Accounting:
Noriaki Hirao
Executive Officer & General Manager-Manufacturing:
Tetsuji Nishioka
Executive Officer & Manager-Healthcare Business:
Fujito Owaki
Executive Officer & Manager-Mail Order Sales:
Yoshihiro Ogawa Shareholders
KOBAYASHI AKIHIRO /KOBAYASHI PHARMACEUTICAL/ (11.8%)
Kobayashi Foundation (7.6%)
WATANABE IKUKO (3.1%)
MFS International (UK) Ltd. (3.1%)
Ohtori Ltd. (2.7%)
MIYATA FAMILY /KOBAYASHI PHARMACEUTICAL/ (2.6%)
Kobayashi Pharmaceutical Co., Ltd. (2.6%)
Nomura Asset Management Co., Ltd. (2.4%)
IUE YUKAKO (2.3%)
The Vanguard Group, Inc. (2.0%)
Contact Details Website: http://www.kobayashi.co.jp Address:
KDX Kobayashi Doshomachi Building,
4-4-10 Dosho-machi,
Osaka,
541-0045,
Japan
Phone:
+81.6.6231.1144
Related Companies
Kobayashi Pharmaceutical Global E-Commerce Co. Ltd.
Kobayashi Pharmaceutical Value Support Co., Ltd.
Kiribai Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Logistics Co. Ltd.
Kobayashi Healthcare International, Inc.
Jiangsu Kobayashi Pharmaceutical Co. Ltd.
True Nature Co. Ltd.
Kobayashi Pharmaceutical Aoitori Foundation
Kobayashi America Manufacturing LLC
Hefei Kobayashi Daily Chemicals Co. Ltd.
PT Kobayashi Pharmaceutical Indonesia
Kobayashi Healthcare LLC
Kobayashi Healthcare (Malaysia) Sdn. Bhd.
Kobayashi Pharmaceutical (Taiwan) Co. Ltd.
Kobayashi Healthcare of America, Inc.
Shanghai Kobayashi Pharmaceutical Business Co. Ltd.
Hefei Kobayashi Daily Products Co. Ltd.
Kobayashi Healthcare (Thailand) Co., Ltd.
PT Kobayashi Eglin
KOBAYASHI Pharmaceutical (Singapore) Pte Ltd.
Kobayashi Pharmaceutical (Hong Kong) Co., Ltd.
Kobayashi Healthcare Australia Pty Ltd.
Kobayashi Healthcare Europe Ltd.
Rokuyou-Seiyaku, Inc.
Kobayashi Medical America LLC
Archer Corp. (Japan)
Meitan Hompo Co. Ltd.
Kobayashi Pharmaceutical Business Association
Ehime Kobayashi Pharmaceutical Co. Ltd.
Kobayashi Pharmaceutical Distribution Co. Ltd.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Last Updated on 3 Feb, 2023
Take your reading anywhere with offline reading functions Never miss a story with breaking news alerts Customize your reading experience
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close